News List
Geneva, December 10, 2024- Razi Institute held a pivotal meeting with delegates from the World Health Organization (WHO) on Tuesday, November 10, in conjunction with fifth session of the Working Group on the Strengthening of the Biological Weapons Convention (BWC). This session aimed to tackle urgent public health issues and foster deeper collaboration between Razi Institute and WHO.
Geneva, Switzerland – In a significant step toward enhancing international cooperation on biological safety, Razi Institute had a meeting with the Russian research center ARRIAH during the fifth session of the Biological Weapons Convention (BWC). This meeting followed a seminar showcasing ARRIAH's research and educational capabilities, attended by Dr. Nikita Lebedev, head of international affairs at ARRIAH, and coordinated by the Iranian delegation in Geneva.
Geneva, Switzerland – The fifth session of the Working Group on the Strengthening of the Biological Weapons Convention (BWC) is scheduled to take place from December 2 to 13, 2024, at the United Nations Office in Geneva. This meeting aims to advance international cooperation and enhance the implementation of the BWC as state parties navigate the increasingly complex landscape of biological threats.
The Vaccines and Immunization Devices (VAX) team of the Prequalification Unit (PQT) in the Department of Regulation and Prequalification (RPQ) of the World Health Organization holds a workshop on risk-benefit assessment of snake antivenom immunoglobulin products for use in Africa, the Middle East, and South Asia in Dubai, UAE – December 3-4, 2024.
On February 17-18, 2025, the Razi Institute will hold an online seminar titled “Venomous Animals & Antivenoms: Bridging Science, Innovation, and Global Health.” This event aims to be a leading forum for advancing scientific knowledge and fostering collaboration in the study of venomous animals and the development of antivenoms. The ultimate objective of this event is to reduce the global incidence of fatalities and casualties resulting from venomous animal bites and stings.
On Tuesday, November 26, 2024, the Razi Institute, in collaboration with the Ministry of Agriculture-Jahad and the Ministry of Foreign Affairs, hosted an online meeting with economic counselors from Iranian embassies across Central Asia, including Kazakhstan, Kyrgyzstan, Uzbekistan, Turkmenistan, Azerbaijan, Tajikistan, and Armenia.
On Wednesday, November 20, a groundbreaking product from the Shiraz branch of the Razi Vaccine and Serum Research Institute was unveiled during a ceremony attended by Mr. Hossein-Ali Amiri Governor of Fars, Dr. Gholamreza Gol Mohammadi the Deputy Minister of Agricultural Jahad & the President of the Agricultural Research, Education, and Extension Organization, Dr. Ali Es-haghi, Director General of Razi Institute, Board of Directors of Razi Institute, and other regional officials. For the first time in the world, researchers at the Razi Vaccine Institute's Shiraz branch have successfully developed a novel vaccine for bovine theileriosis after a decade of research. Dr. Ali Es-haghi hailed this achievement as a significant milestone, praising the innovation, dedication, and perseverance of the Research & development team.
On Monday, November 18, 2024, Dr. Gholamreza Gol Mohammadi, the Deputy Minister and President of the Agricultural Research, Education, and Extension Organization (AREEO), visited the Razi Vaccine & Serum Research Institute. During his visit, Dr. Gol Mohammadi underscored the urgent necessity of establishing an international policy council aimed at addressing the diverse challenges confronting the international offices operating under the organization’s supervision.
The meeting of international offices under the Agricultural Research, Education, and Extension Organization (AREEO) was held on Monday 18 November 2024 in the presence of Deputy Minister of Agriculture Jahad and Director General of Razi Vaccine and Serum Research Institute, in Karaj.
On November 5, 2024, Razi Vaccine and Serum Research Institute proudly unveiled three new vaccines for livestock and poultry during a special event. The ceremony, held at the Plus Hotel in Mashhad, drew esteemed figures from the veterinary science community. HamidReza Farzin, head of Razi Institute's Mashhad branch, commended the dedication and expertise of the researchers and scientists who played a pivotal role in developing these new vaccines.
On Wednesday, October 23, Razi Institute participated in the 23rd Annual Consultation between the Global Polio Eradication Initiative (GPEI) and key stakeholders, including polio vaccine manufacturers, National Authorities for Containment (NACs), and National Regulatory Authorities (NRAs) on 23 October 2024. Dr. Masood Ghader, Deputy of Quality Assurance at Razi Institute, represented Razi Institute at this significant event.
On Monday, October 21, Razi Vaccine and Serum Research Institute held the national seminar on avian influenza at Mirshamsi Conference Hall on 21 October, 2024. The event aimed to share the latest research findings and foster collaboration among experts in the field.
In a pivotal move towards enhancing international collaboration in vaccine production, the Razi Institute has signed a marketing and export memorandum of understanding (MOU) with the private sector in Tanzania. The agreement was witnessed by Iran's Minister of Agriculture-Jahad, Gholamreza Nouri Ghezeljeh, and Tanzania's Minister of Foreign Affairs, January Yusuf Makamba, on October 19 in Dar es Salaam.
Demonstrating its unwavering commitment to global health, Razi Institute took part in the 25th Annual General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN), held from October 16-18 in São Paulo, Brazil. This pivotal event convened leading figures in the vaccine manufacturing industry, emphasizing the importance of collaboration and innovation to address pressing health challenges worldwide.
Dr. Rainak Ghaderi, head of the Academic Relations and International Affairs Office at Razi Institute, has announced the launch of seven specialized training workshops focused on vaccine production, supported by the World Health Organization (WHO). During the inaugural webinar held in Kaveh Hall, Ghaderi highlighted that, following previous training workshops organized by the WHO country office, the Academic Relations and International Affairs Office at Razi Institute successfully secured the capacity to conduct these workshops to enhance vaccine production capabilities.
The National Veterinary Day took place on October 5, 2024, at the Persian Gulf Hall of the Niroo Research Institute. The event was attended by the Minister of Agriculture, and prominent figures in veterinary medicine, and featured a congratulatory message from the President to veterinarians.
The 9th International Exhibition on Pharmaceuticals and Related Industries (Iran Pharma 2024) took place from October 2-4 at the Grand Musalla in Tehran, attracting over 750 domestic and international companies. The event was inaugurated by the Minister of Health, Treatment, and Medical Education, underscoring its significance in the pharmaceutical landscape.
Following the successful execution of the side event titled "Cooperation and Development in Biological Sciences and Technologies: Benefits and Obstacles," held on August 20 during the Fourth Meeting of the Working Group on Strengthening the Biological Weapons Convention at UN Headquarters, the Ministry commends the Razi Institute for its significant contributions to vaccine and serum research and production as well as its supportive role in organizing this side event. Furthermore, the Ministry highlights the outstanding presentation by Dr. Rainak Ghaderi, the head of Academic Relations and International Affairs of Razi Institute, which greatly enriched the discussions and positively influenced the attending member states.
